-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Craniopharyngioma is a saddle-shaped tumor and is associated with a higher incidence of pituitary gland defects (~98%) and hypothalamic obesity (~50%)
.
Recently, a research article was published in the Journal of Clinical Endocrinology & Metabolism, an authoritative journal in the field of endocrine and metabolic diseases.
The study aims to determine the long-term weight loss of patients with hypothalamic dysfunction and obesity of craniopharyngioma after bariatric surgery.
Curative effect
.
In this retrospective case-control study, the participants were obese patients with craniopharyngiomas (N=16; 12 women) with a history of bariatric surgery [12 Roux-en-Y gastric bypass surgery, 4 sleeves Gastrectomy; median age was 21 years (range 15-52), median follow-up was 5.
2 years (range 2.
The average weight loss of the patients at the 5-year follow-up was 22.
0% (95% CI 16.
During the 5-year follow-up after bariatric surgery, the average weight of obese patients with craniopharyngioma dropped by 22%, regardless of the type of bariatric surgery
Original source:
Selveta S van Santen.
et al.
Bariatric Surgery for Hypothalamic Obesity in Craniopharyngioma Patients: A Retrospective, Matched Case-Control Study .
JCEM.
2021.
Bariatric Surgery for Hypothalamic Obesity in Craniopharyngioma Patients : A Retrospective, Matched Case-Control Study in this message
